Kalvista Pharmaceuticals

Quarterly Financials

Values in thousands 2024-07-31 2024-04-30 2024-01-31 2023-10-31
Revenue
$0
$1,206
$0
$0
Gross Profit
-224
987
-207
-197
EBITDA
-43,991
-48,236
-32,944
-28,250
EBIT
-44,215
-48,455
-33,151
-28,447
Net Income
-40,443
-44,650
-29,028
-27,650
Net Change In Cash
0
1,206
0
0
Free Cash Flow
-40,241
-15,521
-27,590
-20,030
Cash
31,848
31,789
23,056
57,666
Basic Shares
46,232
43,590
34,723
34,565

Annual Financials

Values in thousands 2024-04-30 2023-04-30 2022-04-30 2021-04-30
Revenue
$0
$0
$0
$12,690
Gross Profit
-86,167
-802
-743
12,039
EBITDA
-139,629
-110,243
-94,512
-58,233
EBIT
-140,445
-111,045
-95,255
-58,884
Net Income
-126,644
-74,853
-68,512
-44,494
Net Change In Cash
0
0
0
12,690
Cost of Revenue
24,270
-18,693
34,292
Free Cash Flow
-89,674
-76,457
-79,065
-30,253
Cash
31,789
56,238
30,732
50,592
Basic Shares
36,786
27,890
24,473
19,094

Earnings Calls

Quarter EPS
2024-07-31
-$0.87
2024-04-30
-$1.02
2024-01-31
-$0.84
2023-10-31
-$0.80